|
Sponsored by 
|
|
|
|
|
|
|
By Ed Silverman
Drew Angerer/Getty Images
The drug maker explained the recall is taking place now as a “precautionary measure” due to “possible contamination” caused by an impurity called NDMA.
Read More
|
|
By Ed Silverman
Alex Wong/Getty Images
The episode began early last month when the drug maker pulled Natpara, which is used to treat a rare endocrine disorder known as hypoparathyroidism.
Read More
|
|
By Nicholas Florko
Nicholas Florko/STAT
Republicans offered amendment after amendment to try to change the bill — some snarky and political, some more serious. Democrats rejected all of them.
Read More
|
|
Sponsor content by Insmed
Managing life with chronic lung disease
Nontuberculous mycobacterial lung disease is a chronic, debilitating condition that can cause severe, permanent damage to the lungs. While everyone potentially encounters NTM bacteria through routine activities such as taking a shower, washing dishes, or gardening, not everyone is at risk for this rare condition. Visit AboutNTM.com to learn more about how this serious disease affects the daily lives of those living with the condition.
|
|
By Nicholas Florko
Kathy Young/AP
GW Pharmaceuticals makes the first-ever CBD-based prescription drug. Here’s what it wants to do with the marijuana derivative next.
Read More
|
|
By Helen Branswell
DANIEL LEAL-OLIVAS/AFP/Getty Images
A panel of the European Medicines Agency recommended conditional marketing authorization for Merck’s experimental Ebola vaccine.
Read More
|
|
By Ed Silverman
Alex Hogan/STAT
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read More
|
|
